Free Trial

MiNK Therapeutics (INKT) News Today

MiNK Therapeutics logo
$0.70 +0.02 (+2.92%)
(As of 11/20/2024 ET)
HC Wainwright Lifts Earnings Estimates for MiNK Therapeutics
MiNK Therapeutics Reports Q3 Growth and Strategic Advances
Q3 2024 Mink Therapeutics Inc Earnings Call
Promising Developments in MiNK Therapeutics Drive Buy Rating
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
MiNK Therapeutics presents data on iNKT cell therapy programs
MiNK Therapeutics Appoints Dr. Robert Kadlec to Board
MiNK Therapeutics appoints Robert Kadlec to board of directors
MiNK Therapeutics faces potential Nasdaq delisting
Q1 2024 Mink Therapeutics Inc Earnings Call
MiNK Reports First Quarter 2024 Results
MiNK Reports Fourth Quarter and Year-End 2023 Results
Earnings Outlook For MiNK Therapeutics
Get MiNK Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for INKT and its competitors with MarketBeat's FREE daily newsletter.

Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

INKT Media Mentions By Week

INKT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INKT
News Sentiment

0.22

0.45

Average
Medical
News Sentiment

INKT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INKT Articles
This Week

16

1

INKT Articles
Average Week

Get MiNK Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for INKT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INKT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners